Physician profile
Peter B Lee
NPI 1669821633
$1,378.78
in general payments reported to CMS, 2019-2025
8 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $118 · 2023: $491 · 2024: $343 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $398.45 | 2024-2025 | Spark |
| American Orthodontics Corporation | $370.86 | 2021-2025 | Empower-Metal, Lp and Ifit Tubes, Radiance |
| Ormco Corporation | $329.03 | 2021-2023 | Spark, Simpli5 |
| Nobel Biocare USA | $220.21 | 2023 | Nobelactive |
| Align Technology, INC. | $18.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.78 | 2024 | Eliquis |
| 3m Company | $13.18 | 2023 | 3m Filtek, 3m Relyx |
| Ultradent Products INC | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.